The pharmaceutical content bottleneck costs $60M in lost NPV for every month of delay. Transform your 6-8 week asset cycles into days.
Q1 Product Launch Campaign
47 citations auto-verified against source documents
Risk/benefit ratio compliant with FDA guidelines
Awaiting Dr. Chen's approval on efficacy claims
Regulatory compliance certification
After 12-15 years and billions in R&D, pharmaceutical launches are delayed by the content bottleneck. Every month of MLR delay costs $60M in net present value.
The industry average for Medical, Legal, and Regulatory review is 40 days. Legal reviewers alone average 8.2 days per asset due to competing priorities.
A single Digital Sales Aid costs $100K+ to produce. Rep-triggered emails cost $30K. 2,000 hours of labor annually just for creation.
OPDP handles 68,000+ Form 2253 submissions annually. Every claim must be annotated to specific PI pages or clinical literature.
Autonomous compliance checking, modular content libraries, and AI-powered reference validation built for FDA-regulated promotional materials.
AI scans drafts for off-label statements, missing risk information, and fair balance issues before human review. Catch errors in real-time, not after 40 days.
Pre-approved claim modules with attached references. Build new assets by assembling validated blocks. 40%+ content reuse vs. starting from zero.
Every claim automatically mapped to PI pages, clinical studies, and source literature. 100% reference annotation for Form FDA 2253 submissions.
Medical, Legal, and Regulatory review simultaneously instead of sequentially. Single source of truth eliminates versioning confusion.
80% of drug launch success is determined in the first six months. Content velocity isn't optional — it's the difference between market leadership and failure.
MSL-ready materials 18-24 months before PDUFA date
OPDP-ready materials for voluntary 45-day review
Rep-triggered emails, DSAs, social — all from one modular library
4-8 week agility cycles for safety or PI changes
Oncology Brand Launch
42-day average MLR cycle
3.5 review rounds per asset
$2.4M annual content spend
14-day MLR cycle achieved
1.3 review rounds average
$840K annual content spend
2 months faster to market
$120M NPV captured
Stop losing $60M per month of delay. Transform your MLR pipeline from a 40-day bottleneck into a 14-day competitive advantage.
Enterprise pricing available. Contact us for volume licensing and custom integrations with Veeva Vault.